Scarica l'app Stockscreener
19.57
0.28%
-0.055
Nuvectis Pharma Inc Borsa (NVCT) Ultime notizie
Nuvectis Pharma announces public share offering to support drug programs - MSN
Insider Buying: Ron Bentsur Acquires Additional Shares of Nuvect - GuruFocus
Nuvectis Pharma CEO Ron Bentsur buys $250,000 in company stock By Investing.com - Investing.com South Africa
[Form 4] Nuvectis Pharma, Inc. Insider Trading Activity - Stock Titan
Form 4 Nuvectis Pharma Inc For: 1 July By Investing.com - Investing.com India
Nuvectis Pharma 10% owner Mosseri buys $916k in shares - Investing.com UK
Nuvectis Pharma (NVCT) CEO Ron Bentsur buys $250,000 in shares - Stock Titan
Nuvectis: 'Hold' On NXP800 Removal And Newly Licensed Candidates (NASDAQ:NVCT) - Seeking Alpha
What Makes Nuvectis Pharma, Inc. (NVCT) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Nuvectis Raises $100M for Oncology Pivot - AllSci
Nuvectis Pharma Announces Major Public Equity Offering - TipRanks
Form 424B5 Nuvectis Pharma Inc For: 30 June By Investing.com - Investing.com Canada
Nuvectis Pharma Sets 5M-Share, $20 Offering; ~$93M Net, Cantor Fitzgerald Underwriter - TradingView
Nuvectis Pharma (NASDAQ: NVCT) to raise $100M in stock sale - Stock Titan
Nuvectis Pharma (NVCT) files $100M offering; 5.0M shares at $20.00 - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Nuvectis gains two experimental drugs in licensing deal with China's Haisco - MSN
Nuvectis shares continue to rally after $1.46B Haisco deal - BioWorld News
Nuvectis Pharma shares slide after pricing $100 million discounted stock offering (NVCT) - Yahoo Finance
Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big Stoc - Benzinga
Nuvectis Pharma stock tumbles 25% on discounted offering By Investing.com - Investing.com Canada
Nuvectis Pharma Prices $100 Million Secondary Stock Offering; Shares Down Pre-Bell - Moomoo
Nuvectis Pharma's $100 Million Offering: Dilution at a Discount Amidst Pipeline Hopes - Kavout | AI
Nuvectis locks in $100M from 5 million-share stock sale - Stock Titan
Nuvectis Pharma Intends to Use Net Proceeds From Offering to Advance Development Programs >NVCT - Moomoo
Nuvectis Pharma prices $100 million public offering at $20/share By Investing.com - Investing.com Australia
Nuvectis Pharma Prices $100 Million Underwritten Public Offering of Common Stock - Quiver Quantitative
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock - GlobeNewswire
Form 424B5 Nuvectis Pharma Inc For: 29 June - Investing.com UK
Form 424B5 Nuvectis Pharma Inc For: 29 June By Investing.com - Investing.com Australia
Nuvectis Pharma launches public offering of common stock By Investing.com - Investing.com Australia
Nuvectis Pharma stock tumbles on public offering launch By Investing.com - Investing.com South Africa
Nuvectis Pharma prices $100 million public offering of common stock - scanx.trade
Nuvectis Pharma Suspends Equity Offering Program Under Agreement - TipRanks
Nuvectis (NASDAQ: NVCT) prelim prospectus; Haisco license, $20M upfront - Stock Titan
Nuvectis Pharma launches public offering of common stock - Investing.com
Nuvectis Pharma Launches Proposed Public Stock Offering - Moomoo
Nuvectis Pharma stock tumbles on public offering launch - Investing.com UK
Nuvectis Pharma moves to raise capital through proposed public stock sale - Traders Union
Nuvectis Pharma (NASDAQ: NVCT) cuts and suspends $5M ATM share sales - Stock Titan
Nuvectis Pharma seeks fresh capital for cancer and immune programs - Stock Titan
Nuvectis Pharma, Inc.(NasdaqCM: NVCT) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Nuvectis Pharma Up 97%, Insider Buyers Are Up 344% - simplywall.st
Enterprise value to revenue forward of Nuvectis Pharma, Inc. – NASDAQ:NVCT - TradingView
Enterprise value to EBIT forward of Nuvectis Pharma, Inc. – NASDAQ:NVCT - TradingView
Price to book forward of Nuvectis Pharma, Inc. – NASDAQ:NVCT - TradingView
What makes Nuvectis Pharma (NVCT) a new buy stock - MSN
What Makes Nuvectis Pharma (NVCT) a New Buy Stock - Yahoo Finance
Nuvectis Pharma, Inc. Actuals & Estimates (NASDAQ:NVCT) - TradingView
Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade - MSN
NVCT Forecast — Price Target — Prediction for 2027 - TradingView
Haisco and Nuvectis sign licensing deal for two drugs - MSN
Haisco licenses two drug candidates to Nuvectis in potential $1.4 billion deal - Indian Pharma Post
Nuvectis Pharma Up Over 32%, On Pace for Record High Close -- Data Talk - Moomoo
1.05%
0.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):